Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1+ mouse BA/F3 cells
Sofia von Palffy(BC Cancer Agency), Philip Beer(Genoscience Pharma (France))
Cited by 2
Related Papers
Societal challenges of precision medicine: Bringing order to chaos
|European Journal of Cancer|2017|29